Alexey V. Sorokin

机构：The University of Texas MD Anderson Cancer Center · ORCID：0009-0000-7195-6868

发表论文 296 篇 · 总被引 3892 次 · h-index 29

代表论文

Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers (2025 · Cell Reports Medicine · 被引 6)
Abstract B119: FMC-376, a dual inhibitor of ON + OFF states of KRAS G12C, is active in sotorasib resistant PDX models (2025 · Molecular Cancer Therapeutics · 被引 2)
Reprogramming of Cellular Plasticity via ETS and MYC Core-Regulatory Circuits during Response to MAPK Inhibition in BRAF -Mutant Colorectal Cancer (2026 · Clinical Cancer Research · 被引 1)
Figure S1 from Reprogramming of Cellular Plasticity via ETS and MYC Core-Regulatory Circuits during Response to MAPK Inhibition in BRAF-Mutant Colorectal Cancer (2026)
Figure S2 from Reprogramming of Cellular Plasticity via ETS and MYC Core-Regulatory Circuits during Response to MAPK Inhibition in BRAF-Mutant Colorectal Cancer (2026)
Supplementary Methods 1 from Reprogramming of Cellular Plasticity via ETS and MYC Core-Regulatory Circuits during Response to MAPK Inhibition in BRAF-Mutant Colorectal Cancer (2026)